
65 segments available
Michael Mina is an immunologist, epidemiologist, and physician at Harvard. Please support this podcast by checking out our sponsors: - Notion: https://notion.com/startups to get up to $1000 off team plan - Quip: https://getquip.com/lex to get first refill free - Theragun: https://therabody.com/lex to get 30 day trial - Athletic Greens: https://athleticgreens.com/lex and use code LEX to get 1 month of fish oil - Four Sigmatic: https://foursigmatic.com/lex and use code LexPod to get up to 60% off EPISODE LINKS: Michael's Twitter: https://twitter.com/michaelmina_lab PODCAST INFO: Podcast website: https://lexfridman.com/podcast Apple Podcasts: https://apple.co/2lwqZIr Spotify: https://spoti.fi/2nEwCF8 RSS: https://lexfridman.com/feed/podcast/ Full episodes playlist: https://www.youtube.com/playlist?list=PLrAXtmErZgOdP_8GztsuKi9nrraNbKKp4 Clips playlist: https://www.youtube.com/playlist?list=PLrAXtmErZgOeciFP3CBCIEElOJeitOr41 OUTLINE: 0:00 - Introduction 1:22 - At-home COVID-19 tests 11:25 - Medical devices and FDA classification 17:44 - Rapid test availability 34:07 - Who is in charge of public health? 50:46 - Testing privacy 58:02 - Biden's COVID-19 Action Plan 1:09:15 - Uncertainty, fear, and COVID 1:16:10 - Vaccines and herd immunity 1:24:50 - Meditation and consciousness 1:34:52 - Minimalism and Capitalism 1:38:28 - The future of humanity SOCIAL: - Twitter: https://twitter.com/lexfridman - LinkedIn: https://www.linkedin.com/in/lexfridman - Facebook: https://www.facebook.com/lexfridman - Instagram: https://www.instagram.com/lexfridman - Medium: https://medium.com/@lexfridman - Reddit: https://reddit.com/r/lexfridman - Support on Patreon: https://www.patreon.com/lexfridman
Michael Mina discusses the critical role of rapid at-home COVID-19 testing as a solution to the pandemic. He emphasizes the tests' high accuracy in detecting contagiousness, their potential for mass production, and how they empower individuals with information about their health, ultimately minimizing the pandemic's impact on society and the economy.
"the following is a conversation with michael minna his second time on the podcast he's a professor at harvard doing research on infectious disease and immunology in my view the most powerful doable an..."
Mina reflects on the evolution of public understanding regarding rapid at-home testing over the past 20 months. He notes how the availability of these tests has shifted the conversation around COVID-19, empowering individuals and changing political discussions about public health measures.
"to support it please check out our sponsors in the description and now here's my conversation with michael minna we spoke a year ago about rapid at-home testing and i think you think it should have be..."
In this segment, Mina explains the differences between rapid antigen tests and PCR tests. He highlights the importance of rapid tests in determining infectiousness, arguing that their speed and accessibility make them more effective public health tools during the pandemic.
"last year and most of this year was about educating scientists educating public health leaders educating physicians to get them to understand that there is a different reason to test in a pandemic tha..."
Mina describes the mechanics of rapid at-home tests, likening them to pregnancy tests. He explains how they provide quick results regarding infectiousness, emphasizing their effectiveness in public health contexts and the need for rapid feedback to prevent transmission.
"so on that front i think finally there is success people are actually understanding and you know i haven't stopped beating this drum for far too long and i like hate rapid tests now so maybe it's good..."
Mina discusses the significance of viral load in determining infectiousness and how rapid tests are designed to detect high viral loads effectively. He critiques the current FDA evaluation methods for tests, arguing that they should focus on infectiousness rather than just sensitivity.
"then you read the result they are extraordinarily effective to answer one question am i infectious and that is the public health question that we need to answer and consistently ask during this pandem..."
Mina addresses common misconceptions about test sensitivity, particularly in relation to PCR tests. He argues that the focus should be on how well rapid tests can detect infectious individuals, rather than comparing them to PCR tests in a way that overlooks their public health utility.
"tool because it's fast because it's accessible we can use them in the home and there's some issues with using them a home we can talk a little bit about what those issues are like reporting and how do..."
Mina emphasizes the urgent need for rapid home tests and discusses the barriers to their widespread availability. He critiques the FDA's classification of these tests as medical devices, which complicates their approval and distribution.
"sensitive if the question is how likely is it to detect me if i'm a super spreader that's a really important one to be able to detect they're all about 100 sensitive so if you have extraordinarily hig..."
In this segment, Mina explains how FDA regulations impact the availability of rapid tests. He argues that the current evaluation criteria do not align with the needs of public health testing, which should prioritize accessibility and frequency over traditional medical device standards.
"you're infectious and for that question they're like 95 up to 100 sensitive when you're most infectious so you have a lot of iron particles in you so i mean that's what it means when you say viral loa..."
Mina discusses the disconnect between testing protocols and the reality of infectiousness. He argues that public health measures should focus on isolating infectious individuals rather than relying solely on PCR test results, which can lead to unnecessary quarantines.
"well for that question i want to have the absolute best sensitivity test regardless of what it means for transmissibility because my patient isn't sitting in my office saying doc do you think i'm infe..."
Mina concludes by discussing the future of COVID testing and the importance of rapid tests in managing public health. He stresses the need for a paradigm shift in how tests are evaluated and utilized to effectively combat the pandemic.
"that's bad public health practice like if i haven't been infectious for three weeks i don't want to have somebody tell me that i need to go and isolate for 10 days just because i happen to use a pcr t..."
Michael Mina explains the critical difference between being infectious and testing positive for COVID-19. He highlights that individuals can test positive on a PCR test long after they are no longer infectious, emphasizing the importance of using tests effectively to avoid unnecessary isolation.
"infectious for 60 days and to be clear people are only infectious for i don't know somewhere between three and seven days but can be positive on a pcr test for 30 to 70 days so i mean it's it's potent..."
Mina discusses the FDA's stringent requirements for medical devices, particularly rapid tests for COVID-19. He argues that the focus on sensitivity and specificity overlooks crucial factors like scalability and accessibility, which are essential for effective public health responses.
"for contagious people or for the infectious stage of an infection then it literally can't it is an impossibility for that test to achieve an 80 sensitivity at a population level against a medical devi..."
Mina reflects on the slow rollout of at-home COVID-19 tests, attributing it to a lack of creativity and initiative from government agencies. He shares his experiences proposing solutions to the White House and the challenges faced due to the perceived lack of available tests.
"why don't we still have hundreds of millions of at home tests the reason it's taking long i think is because every agency and government is generally deferential to the fda and in this context i would..."
Mina argues for the establishment of a public health pathway for evaluating COVID-19 tests, separate from the FDA's medical device classification. He emphasizes the need for a new definition of public health tools to facilitate rapid testing and improve response to health emergencies.
"they say you know what i get back is this sounds really interesting michael uh it looks like it checks out but there's one problem we don't have the test there's no scale and that's kind of where it a..."
Mina proposes that the President could use executive powers to classify COVID-19 testing tools as public health tools, which would relieve the FDA of its current constraints. This change could enable faster deployment of effective testing solutions during health emergencies.
"the i think what the real reason is the fda has one job around these tests and it is to authorize them as medical devices they haven't been charged with doing anything else so in their eyes they're do..."
Mina discusses the inconsistencies in how the FDA regulates rapid tests compared to pooled testing methods. He critiques the current system that requires rapid tests to meet medical device standards while pooled tests operate without similar oversight.
"they get applications and they evaluate them and the applications are for medical claims that's however because there's been a misunderstanding of these tests and the companies only know to apply for ..."
Mina examines the rationale behind the FDA's classification of tests and the implications for public health. He highlights the absurdity of requiring individual tests to be classified as medical devices while pooled tests are treated differently despite similar public health purposes.
"the fda very clearly states that they do not authorize or review public health tools and not and they don't authorize or review public health tests for for covid so what i want the president of the un..."
Mina contrasts the perspectives of public health and medical professionals regarding testing. He argues that the focus on individual test sensitivity can hinder broader public health strategies that prioritize frequent testing and rapid results.
"hook they're not trying to to cram a square peg through a round hole they can say look the antigen tests are not on us anymore at least if they're going to be used for public health like when you test..."
Mina stresses the need for scalable testing solutions during the pandemic. He shares his insights on how frequent testing of asymptomatic individuals can effectively manage outbreaks, emphasizing that the goal is to determine infectiousness rather than individual viral loads.
"manufactured is it possible to just go around all of this and just for somebody to manufacture at scale tests well you if you did that and you just called them you put a claim on them that called them..."
Mina explains the concept of pooled testing, where samples from multiple individuals are tested together. He discusses its effectiveness in large-scale testing scenarios, highlighting the lack of regulatory oversight compared to rapid tests.
"kids so here you have a company that's testing in each pool five to 25 kids at a time millions of kids in a pretty distributed way across the country and all these different labs and the fda doesn't c..."
Mina critiques the FDA's regulatory framework, pointing out the inconsistencies in how different testing methods are treated. He questions why pooled testing is allowed without oversight while rapid tests face stringent regulations despite serving similar public health needs.
"it's a ridiculous reason and it's because the fda says that if a test and this is actually cms that says this and then the fda adopts it if a test alters your behavior if you get a single result and i..."
Mina discusses the influence of physicians on testing decisions during the pandemic. He argues that their focus on individual test accuracy can overshadow the need for broader public health strategies that prioritize accessibility and frequency of testing.
"and each classroom you might have 20 kids each swab their nose in a classroom and all those swabs go into a single tube and then you rinse that tube out with some saline and you run a pcr test on that..."
Mina calls for a shift in mindset regarding COVID-19 testing, advocating for a focus on public health outcomes rather than strict medical accuracy. He emphasizes the importance of rapid testing in controlling the spread of the virus.
"you talk about the public health tools and cdc you look at masks so masks were decided to somehow be an effective tool to help with the pandemic like so i'm sure the evidence that was used there was p..."
Mina shares a personal anecdote about the implications of delayed PCR testing results. He highlights the risks of allowing individuals to interact freely while waiting for test results, underscoring the need for immediate testing solutions.
"a weird role of the dice or is there a better explanation i think it's somewhat of a roll the dice but i also think it's that testing so doctors don't pretend to like really understand much about like..."
Michael Mina discusses the limitations of physicians in addressing public health crises, emphasizing that their primary duty is to 'do no harm' to individual patients. He highlights the disconnect between clinical training and the need for large-scale testing strategies during the COVID-19 pandemic, arguing that physicians are not trained to think about public health on a systemic level.
"line and people are flowing through without going through security that's not on the tsa agent that's not a big systematic problem of that of of the the system and we can't expect that tsa agent to ha..."
Mina critiques the early focus on PCR tests over rapid antigen tests during the pandemic, arguing that the emphasis on sensitivity distracted from the urgent need for frequent testing. He stresses that the goal of testing asymptomatic individuals is to identify potential spreaders quickly, rather than solely focusing on the accuracy of test results.
"at all and so what has happened is doctors got on board early and said oh hell no we've seen these antigen tests before they're not particularly sensitive compared to pcr and and early in the pandemic..."
In this segment, Mina questions who is responsible for making public health decisions during a crisis. He suggests that the CDC should take charge and that the President has the authority to designate rapid tests as public health tools, bypassing traditional FDA regulations to expedite their deployment.
"who is supposed to be so it's understandable that doctors kind of feel that way just like you said do no harm who's supposed to care about public health is it the fda is there some other organization ..."
Mina reflects on how the UK effectively evaluated and deployed rapid antigen tests as public health tools, contrasting it with the slower processes in the U.S. He argues for a more dynamic approach to testing that prioritizes public health over traditional medical device regulations.
"idea i think the cdc that it should start there override the fda well i don't even think it needs to override it and that's why i think these should just be designated as a different tool so that the ..."
Mina expresses concern over the ongoing crisis in testing and public health management during the pandemic. He emphasizes the need for a clear framework to evaluate rapid tests and the importance of acting swiftly to prevent further outbreaks.
"but there's a lot of really good tests out there we just are taking like 6 to 12 months to run trials they're failing because they can't keep up with pcr and if the president were to do this then the ..."
Mina discusses the misconception that vaccines alone will end the pandemic. He highlights that vaccines were primarily evaluated for their ability to prevent disease, not transmission, and warns that new variants and waning immunity could lead to breakthrough cases.
"really we're going to go through this whole pandemic and never figure this thing out that's just really sad you know if we get through this and don't figure out how to evaluate a damn rapid test so ho..."
In this segment, Mina argues for the necessity of ongoing testing even after vaccination. He explains that as long as transmission continues, additional measures are needed to control the spread of COVID-19, emphasizing that herd immunity may not be achievable.
"right after the first clinical trials and i'm sure we were talking about it when when i was last here i would imagine given the timing but those first clinical trials came out and everyone you know ju..."
Mina proposes a dynamic testing strategy where households have access to rapid tests and can adjust testing frequency based on community transmission levels. He advocates for a proactive approach to testing that allows for quick responses to outbreaks.
"like we're okay with people getting ill and letting transmission go because we don't want to worry about it anymore we're not there yet so until we decide we're not going to stop transmission we need ..."
Mina explains the concept of wastewater testing as a method to monitor community virus prevalence. He suggests that this approach can inform testing strategies and help identify outbreaks before they escalate.
"that's the thing so you can you can get a sense of how prevalent the virus is in a particular community by testing the wastewater that's exactly right and so the viral load associated uh the viral loa..."
Mina discusses the importance of managing outbreaks effectively through testing. He emphasizes that even a small percentage of testing can significantly reduce transmission rates and prevent larger outbreaks, advocating for a public health approach that prioritizes community safety.
"we can do that and if you've now gone again you know a week or two with no cases uh identified stop the testing again that's the nice thing that everything changes when people have the tests in their ..."
Mina addresses the manufacturing costs of rapid tests, suggesting that competition can drive prices down significantly. He highlights the potential for affordable testing solutions that can be widely implemented.
"from everything you've seen how cheap can these things get from like in the past year in in terms of the developments you've seen with the various test manufacturers how cheap can it be to make a test..."
Mina emphasizes the need for a reliable system to verify test results, especially in workplaces and schools. He discusses the importance of integrating technology to ensure accurate reporting and compliance with testing protocols.
"profit and so so it's extremely cheap market competition can drive these tests uh way down in terms of cost i think one of the most important features of a rapid test program is what do you do with th..."
Mina shares his experience at a conference where he utilized a digital verification system for COVID-19 testing. He explains how the process works, including QR code scanning and proctoring via video, which ensures that test results are legitimate and can be used as proof for entry into events or travel.
"bring the test into the home but that means we need the technology to enable it and so i was at a conference recently do you know mike milken milken institute he's a very wealthy billionaire but he's ..."
In this segment, Mina addresses the tension between individual privacy and public health reporting in the context of COVID-19 testing. He argues for the right of individuals to know their own health status while also discussing the challenges of maintaining privacy when results are reported to public health agencies.
"that can be considered proof that you yourself use the test and you yourself got a negative so the tools are out here if we want to use them at scale and in fact the cdc uses emed now to enable people..."
Mina elaborates on the complexities of public health reporting and individual rights regarding COVID-19 testing. He suggests that individuals should have the option to opt-out of public health reporting while still being able to access testing, emphasizing the need for trust in public health systems.
"violate people's privacy or sense of freedom absolutely i i think so the way that um right now in the united states they're requesting that these tests get that the results get delivered to public hea..."
Mina proposes a system where individuals can verify their COVID-19 status without mandatory reporting to public health authorities. He discusses the potential for private companies to create services that allow users to maintain control over their health information while still providing necessary verification for entry into public spaces.
"by default they are participating in public health whether they know it or not because they're not going to go get their mom sick by mistake at least most people wouldn't and then also you can create ..."
In this segment, Mina reflects on the challenges faced by private companies in the COVID-19 testing landscape. He discusses the need for innovation in testing technology and the potential for influential figures like Elon Musk to contribute to scalable testing solutions that are both effective and affordable.
"central to the vaccine hesitancy is a distrust of authority in the distrust of government so you're asking you're asking people to get tested and report their status to a centralized authority when th..."
Mina critiques the Biden administration's 'vaccinate or test' policy, arguing that it may coerce individuals into vaccination without addressing the complexities of virus transmission. He emphasizes the need for clear communication about vaccine efficacy and the importance of transparency in public health messaging.
"exist and it's a struggle because for those companies they don't want to fall out of favor with the cdc or with the fda and so this is a big problem in our marketplace in general by having by having p..."
Mina discusses the implications of the Biden administration's COVID-19 action plan, particularly regarding testing and vaccination. He highlights the need for effective public health tools and expresses concern over the adequacy of the proposed testing measures, urging for a more comprehensive approach to managing the pandemic.
"who frankly are just scared they don't know who to trust and we haven't given them a lot of reason to trust public health to be frank so i agree i mean now that you've opened the door i'll just say my..."
Mina expresses concern over the expectation set by the government regarding the availability of rapid tests. He highlights that the proposed 280 million tests are insufficient for the population and warns that this could lead to overwhelming PCR labs, resulting in delays. He advocates for scaling up the production of rapid tests to meet public demand effectively.
"going to be staying in stock on the on the shelves at cvs and walgreens and amazon or whatever so that's crisis number one it's like now the expectation is set for having rapid tests but they're not g..."
In this segment, Mina reflects on the bipartisan support for COVID-19 testing, contrasting it with the politicization of masks and vaccines. He warns that the 'vaccinate or test' policy could politicize testing, which has previously been a unifying public health tool. Mina stresses the importance of maintaining testing as a non-political issue to empower individuals.
"speaking of politics one of the great things about testing maybe you can correct me but for my sense it's one of the only solutions to covid that has not yet been politicized so masks and vaccines whe..."
Mina discusses the emotional aspect of COVID-19 testing, explaining how access to rapid tests can alleviate anxiety and empower individuals. He shares personal insights on how testing can foster a sense of safety and community, allowing people to interact without fear of unknowingly spreading the virus.
"just scaled up months ago people would have we could have delivered it to every household didn't even have to ask people to request to just deliver packages to every home in america by now easily if w..."
Mina posits that the challenges posed by COVID-19 are fundamentally an information problem. He explains how testing can provide critical data to manage outbreaks effectively, contrasting it with the uncertainty that leads to fear and anxiety. Mina argues that widespread testing could prevent unnecessary quarantines and closures.
"worry am i infectious like i was out last night but i do want to go see my mom today you know like am i infectious i don't know and this has created massive anxiety and i can't tell i completely agree..."
In this segment, Mina reflects on how individuals can advocate for better testing policies. He shares his experience with rapidtest.org, which automates the process of contacting congressional representatives. Mina emphasizes the need for public pressure to encourage the government to utilize executive powers to expedite the approval of rapid tests.
"you know and yeah i like what you said the quarantine is an information problem that's absolutely right what is there something you can say to what people can do like listening to this individuals do ..."
Mina discusses the long-term outlook for managing COVID-19, suggesting that society will eventually adapt to the virus. He explains how immunity will build over time through vaccinations and natural exposures, leading to a more manageable situation. Mina emphasizes the importance of testing as a tool for navigating this transition.
"you know this doesn't have to be a six to twelve month endeavor this could be a two day endeavor we actually did it i judged the rapid test x prize and it went great we actually got incredible metrics..."
In this segment, Mina argues that COVID-19 tests should be viewed as tools for information rather than medical devices. He explains how testing can empower individuals to make informed decisions about their health and reduce fear by providing clarity on their infectious status. Mina draws parallels between driving and testing, highlighting the importance of information in navigating public health.
"constant state of uh fear-mongering for different reasons it's almost um it's almost like the virus got deeply integrated not into just our biology but in the game of politics and in the fear mongerin..."
Mina advocates for the use of rapid testing to empower individuals and communities. He discusses how regular testing can help people understand their infectious status and reduce unnecessary isolation. By framing testing as a public health good, he emphasizes the need for accessible and affordable testing options to enhance community safety and compliance.
"out is except the same way out as it was originally which is testing this information it's information yeah and and i think we can do that we can keep outbreaks suppressed with testing because it's in..."
Mina encourages listeners to advocate for testing as a public health tool. He suggests that individuals should pressure local and federal politicians to recognize the importance of testing in managing public health crises. This segment highlights the need for collective action and awareness to change perceptions around testing and its role in society.
"because they can allow people if you use them at a community level you can have enough people know that they're positive enough people are good people that they won't go out and affect others and the ..."
In this segment, Mina discusses the influence of business leaders on public health policy. He argues that those in positions of power should advocate for testing as a public health tool to protect their businesses and communities. Mina emphasizes the importance of collaboration between business leaders and government to ensure that testing is recognized and utilized effectively.
"days and you're sitting there thinking oh i feel fine i don't know why you know there's a lot of asymptomatic spread but if you see the two lines every day then you actually get to you're doing a litt..."
Mina shares his experiences with meditation and its role in achieving mental clarity and emotional balance. He discusses the active effort required to quiet the mind and the benefits of meditation in managing stress and enhancing self-awareness. This segment explores the intersection of mindfulness and personal well-being in the context of modern life.
"with the title like dear potus yeah you know please designate these as public health tools or just start talking about in the media talk it talk about social media anywhere testing is a public health ..."
Mina delves into the concept of detachment from a Buddhist perspective, discussing how it can lead to a deeper understanding of life and suffering. He reflects on the challenges of detachment in Western culture and the potential benefits of adopting a more balanced approach to attachment and emotional responses.
"only protective yeah you mentioned last time you spent time as a buddhist monk we like didn't spend much time talking about i just would love to talk to you about about it a little bit more maybe as u..."
In this segment, Mina reflects on his journey of self-discovery through meditation and the insights gained about consciousness and free will. He discusses the importance of understanding one's mind and the potential for personal growth through mindfulness practices.
"about detachment as a goal detachment from loved ones detachment from objects is kind of easy to reconcile like people understand that yeah i don't want to be too attached to my car or whatever but de..."
Mina discusses the human instinct to respond to suffering and the balance between detachment and compassion. He explores the challenges of maintaining emotional engagement while practicing detachment, emphasizing the importance of empathy in the face of suffering.
"loved it it was you know but it's a it's kind of a dangerous slope because you can kind of get caught up in it and like really start going from okay i'm trying to quiet my mind to almost being like ad..."
Mina shares his thoughts on minimalism and the burdens of material possessions in a capitalist society. He reflects on the peace that comes from living minimally and the stress associated with accumulating possessions, especially as he prepares for a new chapter in life.
"positive and you know this is really it's really such a distinct thing in a relative to our normal lives here in america where we live for rises you know you want happiness and joy and then you also y..."
Michael Mina discusses the psychological burden of material possessions and the appeal of minimalism. He reflects on how societal pressures push individuals towards accumulating more, yet he finds peace in a minimalist lifestyle. Mina emphasizes the importance of recognizing freedom amidst responsibilities and the need to focus on happiness rather than material wealth.
"exactly i mean that's i i do think that that's you know and they're two totally valid ways to live life um they are generally i think they're ingrained in us pretty early in society right and it's har..."
In this segment, Mina shares his thoughts on the stress that comes with accumulating possessions, especially as he prepares for fatherhood. He highlights the importance of meditation in managing the anxiety of material responsibilities and reassures that true happiness doesn't stem from possessions but from relationships and experiences.
"find that to be not peaceful for me it's like i love the night to have the night the idea that if needed i could like pack up and move yeah and not worry about anything do i actually have that in real..."
Mina reflects on the state of American society, suggesting that we may be witnessing the end of a significant historical experiment. He expresses concern over the inability to recognize existential threats like pandemics and climate change, indicating a potential decline in civilization if these issues are not addressed with urgency.
"you're you're born free you live free i mean depends of course which country but in the united states even with all the possessions even with all the burdens of um sort of credit and owing money and a..."
Despite the challenges facing humanity, Mina discusses his perspective on optimism. He acknowledges the potential for worse pandemics and other threats but believes that the good in humanity often prevails. He emphasizes the need for innovation and collective action to improve quality of life, even in the face of significant challenges.
"completely agree with that so in looking at our failure at scale to to engineer to manufacture to deploy tests how do you feel about our prospect as a human civilization are you optimistic so this pan..."
Mina explores the dichotomy of good and bad in human history, suggesting that while negative events can have devastating impacts, the overall trend leans towards improvement. He discusses the importance of recognizing the potential for positive change and the role of innovation in overcoming societal challenges.
"we'll go in terms of civilization i think we're demonstrating a pretty significant inability to recognize the danger when whether that's the pandemic or whether that's climate change i think it's extr..."
In this segment, Mina highlights the importance of innovation during crises, suggesting that humans often rise to the occasion when faced with urgent threats. He discusses various existential risks, including climate change and pandemics, and expresses hope that humanity's cleverness will lead to solutions that improve life quality.
"history um but the question is whether the negative stuff can sometimes peak to the level where everybody's just destroyed but as long as that doesn't happen i i tend to believe that there would be li..."
Mina concludes with a call to action for rapid testing solutions for COVID-19, emphasizing the importance of individual and collective efforts in addressing public health challenges. He expresses gratitude for the opportunity to advocate for these solutions and reflects on the broader implications for society's response to crises.
"and such so how they choose to wield that power you know is an interesting choice and i do hope that you're right in that over time fear will drive companies to produce a better product or whatever yo..."